Nicox Ophthalmics, Inc.
- Nicox Receives FDA Approval of Zerviate (cetirizine ophthalmic solution) 0.24% - May 31, 2017
- Nicox Announces PDUFA Date for Zerviate NDA - April 11, 2017
- Nicox Resubmits AC-170 (Zerviate) NDA to the U.S. FDA - March 9, 2017
- Nicox Receives Complete Response Letter from the FDA Related to GMP on NDA for AC-170 - October 10, 2016
- U.S. FDA grants Priority Review for Nicox’s AC-170 New Drug Application - June 21, 2016
- Nicox submits New Drug Application for AC-170 to U.S. FDA - April 19, 2016
Drugs Associated with Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.